In this study, our results supported the hypothesis that RGS4 led to downregulation of Cyclin D1 and E2F1 expression via inactivation of the GPCR-mediated PI3K/AKT pathway, and as the results, inhibited melanoma cell growth, proliferation and so on. The gene discussed is CCND1; the disease is melanoma.